Sign inGet started

CATELL ROBERT B

Insider CIK 1195325 · BRTX Director · APDN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
BNBX BNB PLUS CORP. A Award deriv2026-03-272026-03-3177,038— $077,038SEC↗
BNBX APPLIED DNA SCIENCES INC A Award2025-10-172025-10-2022,511— $022,512SEC↗
APDN APPLIED DNA SCIENCES INC A Award deriv2023-01-252023-01-2739,428— $039,428SEC↗
APDN APPLIED DNA SCIENCES INC A Award deriv2023-01-252023-01-2775,099— $075,099SEC↗
APDN APPLIED DNA SCIENCES INC A Award deriv2021-11-012021-11-039,948— $09,948SEC↗
APDN APPLIED DNA SCIENCES INC A Award deriv2021-11-012021-11-0319,897— $019,897SEC↗
APDN APPLIED DNA SCIENCES INC A Award deriv2020-05-222020-05-2713,606— $013,606SEC↗
APDN APPLIED DNA SCIENCES INC X Exercise deriv2019-09-122019-09-1626,549— $00SEC↗
APDN APPLIED DNA SCIENCES INC X Exercise2019-09-122019-09-1649,165$0.54 $26.5K77,575SEC↗
APDN APPLIED DNA SCIENCES INC A Award deriv2019-05-172019-05-21198,826— $0198,826SEC↗
BRTX BioRestorative Therapies, D To issuer deriv2019-03-252019-03-27100,000— $00SEC↗
BRTX BioRestorative Therapies, A Award deriv2019-03-252019-03-2729,000— $029,000SEC↗
BRTX BioRestorative Therapies, D To issuer deriv2019-03-252019-03-2729,000— $00SEC↗
BRTX BioRestorative Therapies, A Award deriv2019-03-252019-03-2715,000— $015,000SEC↗
BRTX BioRestorative Therapies, D To issuer deriv2019-03-252019-03-2715,000— $00SEC↗
BRTX BioRestorative Therapies, A Award deriv2019-03-252019-03-2775,000— $075,000SEC↗
BRTX BioRestorative Therapies, D To issuer deriv2019-03-252019-03-2775,000— $00SEC↗
BRTX BioRestorative Therapies, A Award deriv2019-03-252019-03-27100,000— $0100,000SEC↗
BRTX BioRestorative Therapies, A Award deriv2018-10-292018-10-3075,000— $075,000SEC↗
APDN APPLIED DNA SCIENCES INC C Conversion deriv2018-08-312019-07-1825,000— $025,000SEC↗
APDN APPLIED DNA SCIENCES INC C Conversion deriv2018-08-312018-10-0925,000— $025,000SEC↗
BRTX BioRestorative Therapies, P Buy2018-05-092018-05-105,000$2.80 $14.0K80,866SEC↗
APDN APPLIED DNA SCIENCES INC A Award deriv2018-03-152018-03-1974,572— $074,572SEC↗
BRTX BioRestorative Therapies, A Award deriv2017-08-112017-08-145,000— $05,000SEC↗
APDN APPLIED DNA SCIENCES INC A Award2017-06-282017-06-2928,410$1.76 $50.0K28,410SEC↗
BRTX BioRestorative Therapies, A Award deriv2017-06-232017-06-27100,000— $0100,000SEC↗
BRTX BioRestorative Therapies, A Award deriv2017-03-012017-03-0315,000— $015,000SEC↗
BRTX BioRestorative Therapies, A Award2017-03-012017-03-0315,000$3.00 $45.0K75,866SEC↗
BRTX BioRestorative Therapies, A Award deriv2017-02-102017-02-1410,866— $010,866SEC↗
BRTX BioRestorative Therapies, A Award2017-02-102017-02-1410,866$3.00 $32.6K60,866SEC↗
APDN APPLIED DNA SCIENCES INC A Award deriv2016-12-202016-12-2250,758— $050,758SEC↗
BRTX BioRestorative Therapies, P Buy deriv2016-08-052016-08-098,000— $08,000SEC↗
BRTX BioRestorative Therapies, A Award deriv2016-06-102016-06-1429,000— $029,000SEC↗
BRTX BioRestorative Therapies, P Buy deriv2016-05-182016-05-1912,500— $012,500SEC↗
BRTX BioRestorative Therapies, P Buy2016-05-182016-05-1912,500$4.00 $50.0K50,000SEC↗
BRTX BioRestorative Therapies, P Buy deriv2016-03-012016-03-0337,500— $037,500SEC↗
BRTX BioRestorative Therapies, P Buy2016-03-012016-03-0337,500$4.00 $150.0K37,500SEC↗
BRTX BioRestorative Therapies, A Award deriv2016-02-192016-02-2315,000— $015,000SEC↗